Literature DB >> 19832902

Cystatin C as an index of cerebral small vessel disease: results of a cross-sectional study in community-based Japanese elderly.

M Wada1, H Nagasawa, T Kawanami, K Kurita, M Daimon, I Kubota, T Kayama, T Kato.   

Abstract

BACKGROUND AND
PURPOSE: Recent studies have shown that kidney dysfunction is associated with cerebral small vessel disease (SVD). Although creatinine-based estimating equations have been used as the standard measure for the evaluation of kidney function, the accuracy of these is limited in the elderly because of muscle mass decrease with aging. Cystatin C is a more useful measurement than creatinine-based estimating equations for evaluating kidney function, however, the relationship amongst cystatin C, cognitive dysfunction, and cerebral SVD has not been fully examined in community-based elderly.
METHODS: We performed a cross-sectional study using MRI to determine the relationship amongst cystatin C, cognitive function, and cerebral SVD in a total of 604 community-based Japanese elderly.
RESULTS: In this study, subjects with higher cystatin C levels tended to have more lacunas and higher grades of white matter lesions. Although a decline of the Mini-Mental State Examination (MMSE) scores was associated with SVD-related lesions, the relationship between the tertiles of cystatin C and mean MMSE scores was not statistically significant. In the logistic regression analysis, the association between cystatin C and SVD-related lesions was statistically significant, even after adjustment for conventional risk factors and high-sensitivity C-reactive protein. Furthermore, subjects with higher cystatin C levels accompanied with albuminuria had a greater risk for the presence of subclinical cerebral SVD than those with lower cystatin C levels without albuminuria.
CONCLUSIONS: The present study suggests that there is a close relationship between cystatin C and subclinical cerebral SVD, independently of conventional risk factors, in community-based elderly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19832902     DOI: 10.1111/j.1468-1331.2009.02809.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  23 in total

1.  Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals.

Authors:  Robert C Kalayjian; Kevin R Robertson; Jeffrey M Albert; Carl J Fichtenbaum; Todd T Brown; Babafemi O Taiwo
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

2.  Association between Cystatin C and SVD in Chinese population.

Authors:  Huang Guoxiang; Lu Hui; Zhou Yong; Ji Xunming; Chen Zhuo
Journal:  Neurol Sci       Date:  2018-09-19       Impact factor: 3.307

3.  Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study.

Authors:  Kristine Yaffe; Manjula Kurella-Tamura; Lynn Ackerson; Tina D Hoang; Amanda H Anderson; Mark Duckworth; Alan S Go; Marie Krousel-Wood; John W Kusek; James P Lash; Akinlolu Ojo; Nancy Robinson; Ashwini R Sehgal; James H Sondheimer; Susan Steigerwalt; Raymond R Townsend
Journal:  J Am Geriatr Soc       Date:  2014-08-14       Impact factor: 5.562

Review 4.  A population neuroscience approach to the study of cerebral small vessel disease in midlife and late life: an invited review.

Authors:  Dana R Jorgensen; C Elizabeth Shaaban; Clayton A Wiley; Peter J Gianaros; Joseph Mettenburg; Caterina Rosano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-02       Impact factor: 4.733

Review 5.  Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages.

Authors:  Taimur Dad; Daniel E Weiner
Journal:  Semin Nephrol       Date:  2015-07       Impact factor: 5.299

Review 6.  Association Between Cystatin C and the Risk of Ischemic Stroke: a Systematic Review and Meta-analysis.

Authors:  Yan Wang; Wei Li; Jun Yang; Mijuan Zhang; Chun'e Tian; Minjiang Ma; Qian Zhang
Journal:  J Mol Neurosci       Date:  2019-07-17       Impact factor: 3.444

7.  Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals.

Authors:  Mario Riverol; James T Becker; Oscar L López; Cyrus A Raji; Paul M Thompson; Owen T Carmichael; H Michael Gach; William T Longstreth; Linda Fried; Russell P Tracy; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly.

Authors:  Priya Rajagopalan; Helga Refsum; Xue Hua; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2012-11-20       Impact factor: 4.673

9.  Coffee consumption and cystatin-C-based estimated glomerular filtration rates in healthy young adults: results of a clinical trial.

Authors:  Masafumi Saito; Tohru Nemoto; Satoshi Tobimatsu; Midori Ebata; Yulan Le; Kei Nakajima
Journal:  J Nutr Metab       Date:  2011-06-16

10.  Biomarkers of renal function and cognitive impairment in patients with diabetes.

Authors:  Anne M Murray; Joshua I Barzilay; James F Lovato; Jeff D Williamson; Michael E Miller; Santica Marcovina; Lenore J Launer
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.